AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2023
Aug 28, 2023
35200_dirs_2023-08-28_ed6b4afc-8bd8-41ff-a9c8-63d5fb48b210.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-08-25
Reporting Person: McCall Patrick (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-25 | Common Stock | P | 1000 | $1.03 | Acquired | 6263 | Direct |
More from IN8BIO, INC.
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7